Evaluating the role of <scp>Day</scp> 14 bone marrow biopsy and <scp>European LeukemiaNet</scp> risk classification in predicting overall and relapse‐free survival in acute myeloid leukemia

Authors:

Published: 0000-00-00

DOI: HTTPS://DOI.ORG/https://doi.org/10.1002/ajh.27429

Keywords:

Abstract:

Source: